[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-332319-105":59,"doc-detail-332319-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","balancing-the-scales-the-dual-role-of-interleukins-in-bone-metastatic-microenvironments","Balancing the Scales - The Dual Role of Interleukins in Bone Metastatic Microenvironments","","Bone metastases are a frequent, debilitating outcome of advanced cancers, driven by dynamic crosstalk between malignant cells and the bone microenvironment. Interleukins (ILs), as cytokines that regulate immune modulation and inflammation, can promote or restrain disease progression. Pro-inflammatory ILs (e.g., IL-1, IL-6, IL-8) enhance osteoclastogenesis, tumor growth, and angiogenesis, enabling tumor survival and bone breakdown. Anti-inflammatory ILs (e.g., IL-4, IL-10, IL-13) counteract immune dysregulation and osteoclast activity. The review details underlying signaling pathways and evaluates interleukin-targeted therapies, while noting resistance, side effects, and biomarker potential.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/balancing-the-scales-the-dual-role-of-interleukins-in-bone-metastatic-microenvironments/332319/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/balancing-the-scales-the-dual-role-of-interleukins-in-bone-metastatic-microenvironments/332319.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What are the central interleukins discussed in bone metastatic microenvironments?","Question",{"text":113,"@type":114},"The review focuses on pro-inflammatory interleukins such as IL-1, IL-6, and IL-8, and anti-inflammatory interleukins such as IL-4, IL-10, and IL-13, highlighting their opposing roles in disease progression.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do pro-inflammatory interleukins contribute to bone metastases?",{"text":118,"@type":114},"Pro-inflammatory ILs promote osteoclastogenesis, tumor proliferation, and angiogenesis, creating conditions that favor cancer cell survival and accelerate bone degradation.",{"name":120,"@type":111,"acceptedAnswer":121},"What therapeutic and biomarker implications are presented for interleukin signaling?",{"text":122,"@type":114},"Interleukin-targeted strategies (including denosumab, tocilizumab, and emerging agents) are presented as potential approaches to mitigate bone metastases, and interleukins are discussed as diagnostic and prognostic biomarkers for patient stratification.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},332319,1790051477,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review  \nBalancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments  \nAhmad Dawalibi 1, Amal Ahmed Alosaimi 2 and Khalid S. Mohammad 1, *  \nCitation: Dawalibi, A.; Alosaimi, A.A.; Mohammad, K.S. Balancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments. Int. J. Mol. Sci. 2024, 25, 8163 . [https://doi.org/10.3390/ijms25158163](https://doi.org/10.3390/ijms25158163)  \nAcademic Editors: Anna Cie´sli ´nska and Edyta Sienkiewicz-Szłapka  \nReceived: 30 June 2024  \nRevised: 15 July 2024  \nAccepted: 19 July 2024  \nPublished: 26 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Anatomy, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia; [adawalibi@alfaisal.edu](adawalibi@alfaisal.edu)  \n2 College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11432, Saudi Arabia; [441020691@sm.imamu.edu.sa](441020691@sm.imamu.edu.sa)  \n* Correspondence: [kmohammad@alfaisal.edu](kmohammad@alfaisal.edu)  \nAbstract: Bone metastases, a common and debilitating consequence of advanced cancers, involve a complex interplay between malignant cells and the bone microenvironment. Central to this interaction are interleukins (ILs), a group of cytokines with critical roles in immune modulation and inflammation. This review explores the dualistic nature of pro-inflammatory and anti-inflammatory interleukins in bone metastases, emphasizing their molecular mechanisms, pathological impacts, and therapeutic potential. Pro-inflammatory interleukins, such as IL-1, IL-6, and IL-8, have been identified as key drivers in promoting osteoclastogenesis, tumor proliferation, and angiogenesis. These cytokines create a favorable environment for cancer cell survival and bone degradation, contributing to the progression of metastatic lesions. Conversely, anti-inflammatory interleukins, including IL-4, IL- 10, and IL-13, exhibit protective roles by modulating immune responses and inhibiting osteoclast activity. Understanding these opposing effects is crucial for developing targeted therapies aimed at disrupting the pathological processes in bone metastases. Key signaling pathways, including NF-κB, JAK/STAT, and MAPK, mediate the actions of these interleukins, influencing tumor cell survival, immune cell recruitment, and bone remodeling. Targeting these pathways presents promising therapeutic avenues. Current treatment strategies, such as the use of denosumab, tocilizumab, and emerging agents like bimekizumab and ANV419, highlight the potential of interleukin-targeted therapies in mitigating bone metastases. However, challenges such as therapeutic resistance, side effects, and long-term efficacy remain significant hurdles. This review also addresses the potential of interleukins as diagnostic and prognostic biomarkers, offering insights into patient stratification and personalized treatment approaches. Interleukins have multifaceted roles that depend on the context, including the environment, cell types, and cellular interactions. Despite substantial progress, gaps in research persist, particularly regarding the precise mechanisms by which interleukins influence the bone metastatic niche and their broader clinical implications. While not exhaustive, this overview underscores the critical roles of interleukins in bone metastases and highlights the need for continued research to fully elucidate their complex interactions and therapeutic potential. Addressing these gaps will be essential for advancing our understanding and treatment of bone metastases in cancer patients.  \nKeywords: interleukins; bone metastasis; pro-inflammatory; anti-inflammatory; tumor microen","cbCairjMV5umTred","https://ap.wps.com/l/cbCairjMV5umTred","pdf",1071760,37,"English","# Abstract\n# Keywords\n# 1. Introduction\n## Bone microenvironment and metastatic progression\n## Interleukin-mediated inflammatory signaling","[{\"question\":\"What are the central interleukins discussed in bone metastatic microenvironments?\",\"answer\":\"The review focuses on pro-inflammatory interleukins such as IL-1, IL-6, and IL-8, and anti-inflammatory interleukins such as IL-4, IL-10, and IL-13, highlighting their opposing roles in disease progression.\"},{\"question\":\"How do pro-inflammatory interleukins contribute to bone metastases?\",\"answer\":\"Pro-inflammatory ILs promote osteoclastogenesis, tumor proliferation, and angiogenesis, creating conditions that favor cancer cell survival and accelerate bone degradation.\"},{\"question\":\"What therapeutic and biomarker implications are presented for interleukin signaling?\",\"answer\":\"Interleukin-targeted strategies (including denosumab, tocilizumab, and emerging agents) are presented as potential approaches to mitigate bone metastases, and interleukins are discussed as diagnostic and prognostic biomarkers for patient stratification. \"}]","Balancing the Scales - The Dual Role of Interleukins in Bone Metastatic Microenvironments | PDF",1789997690,93]